Circulating noncoding RNAs as early predictive biomarkers in preeclampsia: a diagnostic meta-analysis
- PMID: 34852820
- PMCID: PMC8638188
- DOI: 10.1186/s12958-021-00852-8
Circulating noncoding RNAs as early predictive biomarkers in preeclampsia: a diagnostic meta-analysis
Abstract
Background: We designed a meta-analysis to evaluate the clinical significance and efficacy of circulating noncoding RNAs (ncRNAs) in the early prediction of preeclampsia.
Methods: PubMed, Embase and the Cochrane Library were used to search for literature. The combined prediction performance was evaluated by calculating the area under the summary receiver operator characteristic (SROC) curve. The potential sources of heterogeneity were analysed by meta-regression analysis and subgroup analysis. All statistical analyses and mapping were performed by RevMan 5.3 and Stata 12.0.
Results: A total of 41 studies from 14 articles, including 557 preeclampsia patients and 842 controls, were included in our meta-analysis. All studies collected blood before onset. NcRNAs in blood performed relatively well in predicting preeclampsia. The combined sensitivity was 0.71, the specificity was 0.84, and the area under the SROC curve (AUC) was 0.86. Peripheral blood mononuclear cell (PBMC) samples showed the best diagnostic accuracy. The combined AUC was 0.93. Combined detection was better than single detection, and miRNA was better than circRNA. The heterogeneity of the study was determined by sample size, lncRNA characteristics, lncRNA source and race.
Conclusion: Circulating ncRNAs can be valuable biomarkers used as candidates for noninvasive early predictive biomarkers of preeclampsia and have great clinical application prospects. The clinical value of ncRNAs needs to be tested by further multicentre, comprehensive and prospective studies, and the test criteria should be established.
Keywords: Biomarkers; Diagnostic meta-analysis; Preeclampsia; ncRNAs.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures







References
-
- Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631–644. - PubMed
-
- Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva CF, von Dadelszen P, McIntyre HD, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl 1):1–33. doi: 10.1002/ijgo.12802. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 81960281/Innovative Research Group Project of the National Natural Science Foundation of China
- AB20159031/Guangxi Provincial Key Research and Development Project
- YYZS202008/Special fund for characteristic innovation team of the First Affiliated Hospital of Guangxi Medical University
- 2018AD03001/Guangxi Key Laboratory of Disaster Prevention and Engineering Safety
- ZY20198011/Special project of central government guiding local science and technology development
LinkOut - more resources
Full Text Sources